Clinical Trial Update: Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder

View source ↗

Summary

Post-marketing surveillance update for the GORE CARDIOFORM Septal Occluder in Japan, monitoring safety and outcomes related to stroke and TIA in patients with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptogenic Stroke
• Patent Foramen Ovale
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• GORE CARDIOFORM Septal Occluder

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Stroke, PFO - Patent Foramen Ovale | Status: ACTIVE_NOT_RECRUITING